AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Immuno-Biological Laboratories Co., Ltd.
  3. Financials
  4. Return on Assets

Immuno-Biological Laboratories Co., Ltd.【JP:4570】

Market cap
¥15.7B
P/E ratio
59.3x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndReturn on Assets (Million JPY)YoY (%)
Mar 31, 202514.4+17.58%
Mar 31, 202412.2-166.25%
Mar 31, 2023-18.5+26.35%
Mar 31, 2022-14.6-3.50%
Mar 31, 2021-15.1-39.25%
Mar 31, 2020-24.9+367.54%
Mar 31, 2019-5.3+239.49%
Mar 31, 2018-1.6-97.46%
Mar 31, 2017-61.8+6202.04%
Mar 31, 2016-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)